Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Safety and Efficacy of Different Regimes of Reintroduction of Anti-TB Drugs in Antituberculosis Treatment Induced Hepatotoxicity

NCT00405301 is registered in ClinicalTrials.gov with All India Institute of Medical Sciences as lead sponsor.

NCT NCT00405301
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00405301 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Safety and Efficacy of Different Regimes of Reintroduction of Anti-TB Drugs in Antituberculosis Treatment Induced Hepatotoxicity
Lead sponsor
All India Institute of Medical Sciences
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2006
Completion date
December 31, 2008
Enrollment
175 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

drug induced hepatotoxicity, tuberculosis